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Abstract (245 words) 26 
With ageing there is frequently a loss of appetite, termed anorexia of ageing, which can 27 
result in under-nutrition. We do not know how appetite control alters with ageing. The 28 
objective of this study was to investigate whether differences in the release of, and 29 
response to, gastrointestinal appetite hormones is altered in young compared to old healthy 30 
volunteers. We hypothesised that an increase in PYY and GLP-1 or a decrease ghrelin may 31 
result in a decreased appetite.  A comparative experimental design, using a cross-sectional 32 
sample of ages from a healthy population, matched for sex and BMI was used.  The study 33 
compared total ghrelin, acyl-ghrelin, PYY, GLP-1 and subjective appetite responses to 34 
ingestion of a standardised 2781kj (660kcal) test meal.  31 female volunteers aged between 35 
21-92yrs took part. Multiple linear regression showed that both age and sex had an 36 
independent effect on energy intake. Subjective appetite scores showed that hunger, 37 
pleasantness to eat, and prospective food intake were significantly lower in the older age 38 
groups. PYY incremental area under the curve (IAUC) was greater in the oldest old 39 
compared to younger ages f(3,27)=2.9, p=0.05. No differences in GLP-1, ghrelin or acyl-40 
ghrelin were observed in the older compared to younger age groups.  Our data suggest that 41 
there may be increases in postprandial PYY(3-36) levels in female octogenarians, potentially 42 
resulting in reduced appetite. There does not appear to be any change in ghrelin or acyl-43 
ghrelin concentrations with ageing. 44 
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Introduction 48 
The ageing population is increasing and with ageing there is frequently a loss of appetite, 49 
occurring even in the absence of disease, termed ‘anorexia of ageing’, which can result in 50 
under-nutrition (Morley & Silver 1988). Under-nutrition results in a decline in functional 51 
status, impaired muscle function, poor wound healing, higher hospital admission rates, and 52 
increased mortality, and contributes to increasing healthcare costs (Norman et al. 2008). 53 
Current consensus suggests that under-nutrition is an under diagnosed problem and this is 54 
reflected in national and international guidance about nutritional screening (Kondrup et al. 55 
2003). In the UK, prevalence is estimated to be three million, based on prevalence data from 56 
the community, nursing homes, residential homes, and hospitals (BAPEN Malnutrition 57 
Advisory Group 2009). Centres for Disease Control and Prevention in USA estimate that up 58 
to 3000 people die each year from malnutrition related causes (Lee & Berthelot 2010). In 59 
2006, the rate of malnutrition mortality for all adults was 0.8 per 100,000 people, but for 60 
75-84 years it was 5.2, and for over 85 years it was 20.9 (Lee & Berthelot 2010). 61 
Under-nutrition is normally treated using nutritional supplements, which are effective but 62 
not universally (Milne et al. 2009). Studies have also looked at additional food and eating 63 
assistance, but these also have mixed outcomes (Wade & Flett 2012). Poor outcome of 64 
nutritional interventions appear to be mediated by appetite; if appetite is suppressed it will 65 
limit the consumption of enough food and/or supplements. 66 
Evidence exists to suggest a dysregulation of appetite control with ageing; older adults have 67 
been shown to have an inability up-regulate appetite after periods of under-nutrition 68 
compared to younger. This was related to differences in the sensations of hunger and 69 
fullness and resulted in a failure to regain lost weight (Moriguti et al. 2000). 70 
Appetite is controlled by hormonal and neural factors communicating between the gut and 71 
brain (Hameed S, 2009). Briefly, there are several hypothesised satiety hormones including 72 
cholecystokinin, peptide tyrosine tyrosine (PYY3-36) and glucagon-like-peptide-1 (GLP-1), and 73 
there is only one gastrointestinal hormone which increases food intake, ghrelin. Our team 74 
has demonstrated that the appetite loss in elderly people with fractured neck of femur is 75 
associated with dysregulation of PYY and ghrelin (Nematy et al. 2006b).  However, changes 76 
seen during illness may be different to those related only to ageing. Therefore, there is a 77 
need to investigate whether there are changes in appetite control that occur in healthy 78 
older adults, before overt under-nutrition or illness is evident, that may precede these 79 
conditions and place the older person at greater risk of developing these conditions. In this 80 
study we carefully recruited individuals with no diagnosed health conditions. 81 
Our study hypothesis was that appetite would be suppressed leading to lower energy 82 
intakes in healthy older people, compared with young, and this would be related to either a 83 
decrease in ghrelin or an increase in PYY and GLP-1. 84 
 85 
Methods 86 
The Riverside Research Ethics Committee granted ethical approval for the study (REC No 87 
08/H0706/128). All volunteers gave written informed consent. The study was carried out 88 
between 2009 and 2011, at John McMichael Clinical Research Facility, Imperial College 89 
Healthcare NHS Trust. 90 
Our aim was to investigate the effects of ageing alone on appetite regulation therefore we 91 
recruited healthy subjects from the local community (via posters, adverts in local 92 
organisational newsletters, and through the local General Practitioner research network), 93 
ensuring equal numbers in each age range: 20-39; 40-59; 60-79, 80+ years, and matched 94 
groups for sex and BMI (within ±3kg/m²). We recognise that healthy subjects over 60 years 95 
are not necessarily representative of their population due to the lack of ill health, but 96 
excluding illness was necessary to test whether ageing per se is associated with changes in 97 
appetite control.  The inclusion criteria were no diagnosed acute disease and no chronic 98 
disease or medication known to interfere with gut peptide secretion or appetite (this 99 
excludes virtually all chronic diseases; stable hypertension controlled by medication was the 100 
most common condition allowed). The main exclusion criteria were: history of alcoholism or 101 
substance abuse; raised blood pressure (>90/140mmHg); pregnant or breastfeeding 102 
women; recent treatment with an investigational drug; recent blood donation; current 103 
smokers; scoring 15 or more in restraint section of the Three Factors Eating Questionnaire. 104 
The primary outcome was total ghrelin concentration. Secondary outcomes included acyl-105 
ghrelin, PYY and GLP-1 concentration, insulin and glucose levels, appetite visual analogue 106 
scores, food intake at the ad libitum meal, and gastric emptying. 107 
Volunteers were invited to a screening visit where their body mass index (BMI: kg/m
2
), and body fat percentage (multi-108 
frequency segmental bioelectrical impedance analysis; Tanita Body Composition Analyser, Amsterdam, Netherlands) 109 
were calculated. They were screened for blood abnormalities (full blood count, urea and electrolytes and liver function 110 
tests) and asked about any current medications and illnesses. Participants then completed the restraint section of the 111 
three factors eating questionnaire (Stunkard & Messick 1985) to exclude people with high eating restraint scores that 112 
may affect food intake at the test meal. Finally, subjects chose which ad libitum meal they would prefer. These meals 113 
were manufactured composite meals chosen for their similar macronutrient profiles (see  114 
 115 
Table 1) and homogenous consistency. 116 
 117 
 118 
Table 1: Nutritional Composition of ad libitum meals 119 
Values/100g Bolognese 
bake 
Chicken Tikka 
Masala 
Macaroni 
Cheese 
Energy KJ (kcal) 665 (160) 665 (160) 631 (151) 
Protein (g) 8.5 7.3 7.0 
Carbohydrate (g) 
of which sugars (g) 
15.6 
1.5 
16.6 
3.6 
14.0 
1.0 
Fat (g) 
of which saturates (g) 
6.8 
3.5 
6.9 
2.4 
7.4 
4.8 
Mono-unsaturates (g) 
Poly-unsaturates (g) 
2.7 
0.3 
3.0 
1.1 
2.3 
0.3 
 120 
Subjects then attended for two ½ day visits, arriving at 08.30 fasted (no food and only water 121 
from 9pm the night before) and having avoided alcohol and excessive exercise prior to the 122 
visit. The first visit was a sham visit, mimicking the process for the true test meal except that 123 
minimal blood was taken at each sampling point. Gut hormones are influenced by stress and 124 
therefore a sham visit was necessary to accustom volunteers to the environment and 125 
protocol. (The process for the study is shown in Figure 1S, supplementary data). The second 126 
visit followed this process and the required blood sample volumes were taken. 127 
The standard meal was consumed immediately after the first fasting blood sample and 128 
consisted of 600ml nutritionally complete supplement drink (Ensure plus, Abbott, USA). This 129 
is routinely used in our laboratory as it provides a fixed known amount of macro-nutrients 130 
and energy that can be consumed quickly, ensuring a standardised stimulus for gut 131 
hormone release. Subjects consumed all of the drink over a 15 minutes period 132 
(2781kj/660kcal, 27.5g protein, 89g CHO, 21.6g fat). Directly after the test meal the subjects 133 
took 1.5g of soluble paracetamol to measure gastric emptying. Blood samples and visual 134 
analogue scales were then completed at regular intervals for 3 hours. After 180 minutes the 135 
participants were offered a pre-weighed excess of the chosen meal and asked to eat until 136 
comfortably full. The remaining food was weighed to calculate the energy and nutrient 137 
intake at the meal. Between one and three volunteers were studied at any given time and 138 
no contact was allowed between participants. 139 
All plasma peptide hormones and insulin were measured in duplicate in a single assay. Total 140 
ghrelin (Patterson et al. 2005), total PYY (Adrian et al. 1985b, 1987), GLP-1(1-36) (Kreymann 141 
et al. 1987), and insulin by radioimmunoassay; glucose using hexokinase and G-6-PDH with 142 
Abbott ci8200 analysers (Abbott Diagnostics, Maidenhead, UK); acyl-ghrelin using sandwich 143 
ELISA kit (Millipore, USA) specific for human acyl-ghrelin; and paracetamol using 144 
Enzymatic/Colorimetric method with Abbott ci800 analysers (Abbott Diagnostics, 145 
Maidenhead, UK). The time to peak concentration for paracetamol was used as a 146 
measurement of gastric emptying (Heading et al. 1973). An index of fasting insulin 147 
resistance was measured (HOMA) (Matthews et al. 1985). 148 
Appetite visual analogue scales (VAS) include five scales to assess hunger, nausea, 149 
pleasantness to eat, prospective desire to eat, and fullness (Stubbs et al. 2000). Each scale is 150 
a 100mm line which is marked by the participant and measured to the mark, providing a 151 
score out of 100 assuming 1mm equals a score of one. 152 
Gut hormone concentration and VAS scores are measured over time and thus the area 153 
under the curve (AUC) and the incremental area under the curve (IAUC) were used to 154 
quantify these measures over the whole test meal period. The IAUC includes the area 155 
between the plasma level curve and the fasting concentration (T=0), with any area beneath 156 
fasting being ignored. It is calculated using the sum of the areas of the triangles and 157 
rectangles making up the area, calculated geometrically by applying the trapezoid rule 158 
(Wolever & Jenkins 1986). The IAUC is the preferred method to determine changes over 159 
time since it takes into account the baseline value, however, it could mask the overall effect 160 
of ageing. For example, hunger levels may not decrease significantly more in ageing in 161 
response to a test meal, but overall hunger levels may be consistently lower, demonstrating 162 
an overall effect of ageing rather than just a response to a test meal, therefore AUC was also 163 
used. 164 
For a power of 90% and α=0.05, with a sd=256.6 (Neary et al. 2004) and to detect a 165 
difference of 100pmol/l (difference in total ghrelin levels seen in our previous work and 166 
previously shown to result in altered food intake) 72 patients were needed in total (18 in 167 
each age group). 168 
The sample was grouped by age as follows: 20-39, 40-59, 60-79 and 80 + years. Age groups 169 
were compared either using a one-way ANOVA followed by a Hochberg post-hoc test (for 170 
data judged to be normally distributed using Kolmogorov-Smirnov test) or a Kruskall Wallis 171 
test followed by a Mann Whitney U test (for data judged to be non-normal).  172 
Multiple regression analysis was also used to explore the association of age with hormone 173 
concentration, and the factors potentially affecting total energy intake. Exploratory analyses 174 
were performed with composite variables constructed from the main endpoints, and the 175 
relationship of these composite variables with age was tested with a linear regression 176 
analysis. To construct the composite variables, they were first standardised to a common 177 
scale by dividing each endpoint by its standard deviation, and subtracting the mean value. 178 
Residuals from the regression analysis testing the composite variables were tested for 179 
normality using the Shapiro-Wilk statistic and no statistically significant deviations from 180 
normality were detected. 181 
Results 182 
58 volunteers were recruited (details are shown in figure 2S, supplementary data). All age 183 
group recruitment targets were met except those over 80 years. This proved an extremely 184 
challenging group to recruit, and despite accessing several General Practitioner patient 185 
databases, inviting hundreds of potential patients and screening many, we were only able to 186 
recruit 6 females eligible for the study. Most individuals were not suitable due to 187 
comorbidities and/or current medications. Therefore we have presented here the data for 188 
females only due to the absence of males in the oldest age group (data for the whole group 189 
is in supplementary information). 190 
Demographic details are shown in Table 2. As expected body composition of the older 191 
participants was different to the younger; fat percentage increased and lean percentage 192 
decreased with increasing age. Matching for weight and BMI was effective with no 193 
significant differences between the age groups. 194 
Table 2: Female Participants’ Characteristics 195 
 Mean (SD) 
 Total 
N=31 
20-39 years 
N=9 
40-59 years 
N=9 
60-79 years 
N=7 
80+ years 
N=6 
Age (years) 54.0 (21.8) 27.2 (5.0) 51.2 (7.3) 66.4 (4.8) 85.0 (4.8) 
BMI (kg/m2) 22.9 (1.8) 22.2 (1.4) 23.2 (1.7) 23.4 (1.6) 23.5 (2.7) 
Body Fat (%) 31.9 (7.9)a 28.4 (3.2) 33.5 (13.0) 32.5 (5.4)a 34.0 (4.2) 
Lean Mass (%) 18.5 (1.3)a 19.0 (1.1) 19.0 (1.3) 17.7 (1.1)a 17.7 (1.1) 
Weight (kg) 63.2 (8.1) 61.6 (6.4) 65.1 (6.7) 64.0 (12.2) 61.8 (8.1) 
a=1 missing value; BMI=Body Mass Index. 196 
 197 
Plasma hormone analysis can be seen in Figure 1 and shows statistically significant 198 
differences between the female age groups for PYY IAUC (f(3,27)=2.9, p=0.05). Post hoc 199 
analysis using Hochberg test showed that the 80+ age group had a greater IAUC compared 200 
to the 60-79 at the 0.05 level. All other comparisons were not significant. No significant 201 
differences in GLP-1, acyl or total ghrelin were observed.  The regression analysis found no 202 
associations with age for either PYY, GLP-1 or ghrelin. Further post hoc tests exploring 203 
different age cut offs for the oldest group (either 75+ or 70+) did not change the pattern of 204 
results and only the a priori planned analyses are presented. 205 
Figure 1: Difference in PYY, GLP-1 and Acyl-ghrelin 206 
blood concentrations between age groups 207 
208 
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There was a decline in energy intake at the ad libitum meal from the young to the old 216 
group (ANOVA: f(3,27)=2.9, p=0.05) as shown in Table 3.  217 
Table 3: Energy intake from ad libitum meal (women only) 218 
Age group 
Mean energy (kcal) intake at ad libitum 
meal (±sem) 
20-39 yrs 885.5 (±107.0) 
40-59 yrs 744.0 (±105.3) 
60-79 yrs 684.0 (±130.4) 
80+ yrs 415.6(±72.4) 
 219 
Post hoc testing (Hochberg) revealed significant differences between youngest compared 220 
to oldest age group at the 0.05 level. All other comparisons were not significant.  These 221 
differences were maintained when lean body mass was controlled for, showing a negative 222 
correlation between energy intake (kcal)/lean body mass (kg) (p<0.001, r=-0.66) (see 223 
Figure 2). 224 
Figure 2: Association between age and energy intake (kcal)/kg lean mass from the ad libitum meal. 225 
 226 
A multiple linear regression analysis (including men and women) showed that only age 227 
(p<0.001) and sex (p=0.03) had an independent effect on energy intake at this meal, and 228 
energy expenditure, lean mass and water consumption were all excluded from the final 229 
model. 230 
We also explored the VAS results in the whole cohort, men and women; the Kruskall-231 
Wallis test showed that hunger (H(3)=10.8, p=0.013), pleasantness to eat (H(3)=16.6, 232 
p=0.001), and prospective desire to eat (H(3)=18.4, p=0.001) scores were significantly 233 
affected by age. Pairwise comparisons with adjusted p values showed that hunger was 234 
significantly lower in the oldest compared to the youngest (p=0.016); pleasantness to eat 235 
was reduced for 80+ (p=0.001) and 60-79yrs (p=0.023) compared to the youngest; and 236 
similarly prospective desire to eat was reduced for 80+ (p=0.001) and 60-79yrs (p=0.011) 237 
compared to the youngest. (See Figure 3). Fullness and nausea scores were not different 238 
(data not shown). 239 
  240 
Figure 3: Mean VAS score over time and AUC for hunger, pleasantness to eat, and prospective desire to eat. 241 
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Insulin, glucose and insulin resistance were all raised in the older age groups compared to 245 
the younger group, as expected from previous research data (Fraze et al. 1987). Peak 246 
paracetamol concentrations did not change with age, indicating no difference in gastric 247 
emptying between the four age groups. Further details of this data can be found in the 248 
supplementary data. 249 
 250 
Discussion 251 
This data confirms that healthy older adults have lower energy intake at the ad libitum 252 
meal and lower daily energy expenditure, with age as an independent factor, when 253 
controlled for body composition.  The subjective appetite data (VAS) shows a 254 
corresponding picture of significantly less hunger and desire to eat in older subjects 255 
explaining lower intakes. 256 
We hypothesised that a difference in the pattern of concentration of gut hormones would 257 
account for appetite suppression in older healthy people. The results are inconsistent. 258 
These data suggest that the age related difference in energy intake in those aged over 80 259 
years may result from higher blood concentrations of PYY but not from an increase in GLP-260 
1 or a reduction in ghrelin concentration. The regression analysis using age as a 261 
continuous variable did not support this finding and found no relationship between age 262 
and any hormone blood concentration.   263 
We also found higher insulin, glucose and insulin resistance in the oldest age group as 264 
would be expected, and this may be explained to some extent by the differences in body 265 
fat mass (Paolisso et al. 1999).  We found no difference in gastric emptying between 266 
young and old, thus eliminating this factor as contributing to the reduced food intake. 267 
To date most research to explore appetite control and ageing has focussed on ghrelin 268 
concentration (Moss et al. 2012), testing the hypothesis that a reduction in this appetite 269 
stimulating hormone may explain the decrease in appetite seen with ageing (Moss et al. 270 
2012). The results from these studies are mixed. Part of the reason for this is because 271 
older studies did not measure the two forms of ghrelin; desacyl (inactive) and acyl 272 
(biologically active), but only total ghrelin. Only four of the nine published studies 273 
investigating ageing and ghrelin measured acyl ghrelin (Bauer et al. 2010; Di Francesco et 274 
al. 2008; Nass et al. 2013; Schneider et al. 2008) but even these have used different 275 
methods for acyl-ghrelin analysis (RIA and Sandwich ELISA) which could in part explain the 276 
inconsistent results found in these studies (Prudom et al. 2010). One study compared 277 
ghrelin concentration over 24hr in young and old subjects (Nass et al. 2013) and found 278 
lower levels of ghrelin concentration during the night but not post-prandially. This 279 
supports our results in part, but it is problematic to compare this study to ours as the 280 
purpose and methodologies are different.  Only one other study shows a lower fasting and 281 
post-prandial ghrelin concentrations in older adults (Di Francesco et al. 2008), supporting 282 
the theory that a reduction in ghrelin concentration causes a reduced appetite with 283 
ageing. This study uses the most robust methodology in terms of the calorie content of 284 
the study meals provided, time of day, and the matching of groups on age range, body 285 
mass index and sex. In contrast our study, also carefully designed to limit many of these 286 
methodological problems, does not support the theory that ghrelin concentration is 287 
reduced with ageing.  It should be noted that our study was powered to detect a 288 
100pmol/l difference between groups and the sample size was too low in the oldest age 289 
group.  290 
Many studies have demonstrated that PYY3–36 exerts an anorectic effect in humans 291 
(Batterham et al. 2003; Degen et al. 2005; Sloth et al. 2006). PYY concentrations increase 292 
significantly after a meal in proportion to the amount of calories consumed reaching a 293 
plateau after approximately 1 h and remains at the plateau for up to 6h (Adrian et al. 294 
1985a).  We and others have demonstrated that in a number of chronic conditions and in 295 
critical care, appetite dysregulation is related to increased PYY and/or decreased ghrelin 296 
(le Roux et al. 2005; Nematy et al. 2006a; Nematy et al. 2006b; Oner-Iyidogan et al. 2011). 297 
Increased circulating PYY concentrations, early PYY production post-prandially or 298 
increased sensitivity to PYY in ageing could all result in elevated feelings of fullness, 299 
leading to the cessation of food intake, and may explain the changes in appetite seen 300 
during ageing. Studies exploring the sensitivity to PYY in young healthy adults have shown 301 
ambiguous results and that even near physiological doses can elicit nausea and vomiting 302 
(Batterham et al. 2003; Degen et al. 2005; Sloth et al. 2006), thus such studies in older 303 
adults are challenging to carry out. 304 
There are currently only two studies that have explored the effect of ageing on PYY 305 
production (Di Francesco et al. 2005; MacIntosh et al. 1999). MacIntosh et al (MacIntosh 306 
et al. 1999) found no effect of age when comparing PYY concentrations in young (20-307 
34yrs, n=7) and older (65-80yrs, n=8) male adults (healthy and matched for BMI) during an 308 
infusion of lipid or glucose directly into the duodenum. These researchers aimed to study 309 
small intestine nutrient-mediated feedback, making the method of nutrient delivery 310 
different to normal eating, where the effects of food consumption, nutrients in the 311 
stomach and gastric emptying play a role. It is therefore difficult to compare this evidence 312 
with the current study, but in fact show data in line with those reported here, since the 313 
age of the older group was less than 80 years. The other study aimed, like ours, to 314 
replicate normal eating, albeit in a controlled manner and environment. Di Francesco et al 315 
(Di Francesco et al. 2005) used a study protocol involving an overnight fast followed by a 316 
3347kJ (800kcal; 15% protein, 45% fat, 40% carbohydrates) solid meal with water, 317 
comparing young (25-53yrs, n=9) and older (72-82yrs, n=10) men and women (M:F=10:9), 318 
all healthy and matched for BMI. Their study demonstrated that older subjects had no 319 
difference in fasting PYY or PYY concentrations up to 120 minutes post-prandially, but a 320 
significantly higher concentration at 180 and 240 minutes. An absence of an altered GLP-1, 321 
total ghrelin, acyl ghrelin and gastric emptying with ageing was also observed in this 322 
investigation. These data are in agreement with our findings and are consistent with the 323 
post-prandial satiety effects of PYY which appears to be released in greater quantity in 324 
response to food intake in older individuals. In addition, our data suggest that these 325 
effects are only clearly apparent in the very old healthy population.  This information 326 
supports the hypothesis that ageing is associated with increased PYY production, resulting 327 
in satiety, and offering some explanation for the anorexia of ageing.  Our data also showed 328 
that in the older group there appears to be a suppression of PYY at 15 minutes following 329 
the meal.  The physiological relevance of this is not known.  However there is no 330 
suggestion from the VAS that this cause a decrease in satiety at this time point.  It is also 331 
worth noting that both these studies measured cholecystokinin (CCK) (not done in this 332 
study) and found higher concentrations in older subjects both fasting and post prandially.  333 
Another group has also reported elevated CCK (Sturm, 2003) but Serra-Prat et al was 334 
unable to reproduce this observation (Serra-Prat et al 2009). 335 
The main limitation of this study is the low number of healthy participants over 80yrs 336 
(n=6) and that they were all female, thus it is possible that these results are a type 1 337 
statistical error or due to the sex of the subjects.  We have presented the female only 338 
analysis but the analysis for all data is shown in the supplementary information, 339 
suggesting few differences between the sexes.. There is little published data to suggest an 340 
effect of sex on gut hormone concentration and appetite control and this evidence relates 341 
to phases of the menstrual cycle (Brennan et al. 2009). Larger studies, ideally with both 342 
men and women, using similar standardised protocols are required to confirm our results. 343 
Another limitation is that total PYY was measured not PYY3-36 only. 344 
It is difficult to establish from the published literature exactly what age anorexia may start; 345 
it appears to be a gradual process but is most common along-side chronic disease 346 
(Visvanathan, 2015). Our data shows that food intake decreases even with no ill health 347 
continuing up to 92 years. 348 
We also did not identify an incremental change in PYY concentration in the 60-79yr age 349 
group, as would be expected assuming a gradual alteration in gut hormone concentration 350 
with ageing. However, this is not necessarily a sound assumption as anorexia of ageing 351 
effects the very old to a greater extent (Malafarina et al. 2013). It may be that these 352 
changes in PYY concentration are limited to the oldest age groups.  However, the VAS data 353 
do show a linear reduction of appetite with age, suggesting other factors may be at play. 354 
Appetite remains under the influence of many external factors, such as lifestyle 355 
(retirement), psychological (bereavement, depression) or hormonal (menopause) changes. 356 
These changes may precede later physiological changes suggested from our results.  357 
Although subjects were matched for BMI, percentage body fat was found to be higher in 358 
the oldest age group compared to the youngest and so could be a possible confounder. 359 
However, there is scant evidence that PYY is affected by BMI or fat mass. One study 360 
(Batterham et al. 2003) found lower PYY levels in obese compared to lean young adults, 361 
and a negative relationship between BMI and PYY, suggesting that PYY would be lower 362 
with higher fat mass. Therefore, the difference in fat mass is unlikely to be a significant 363 
factor in the finding that PYY was increased in the oldest age group. 364 
Gastric emptying was also not different between age groups eliminating this factor as one 365 
which contributed to the reduction in food intake seen in our aged study sample. In 366 
theory; increased time to empty the stomach could reduce appetite and speed up satiety. 367 
The use of a small volume meal may have ensured that gastric emptying was not affected 368 
allowing us to conclude that the reduction in food intake is due to the changes in PYY 369 
concentration.  370 
Our data suggest that there may be an increase in the concentration of PYY after meals 371 
with healthy ageing in females, potentially resulting in a reduced appetite. There does not 372 
appear to be any change in ghrelin or acyl-ghrelin concentration with ageing. 373 
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Supplementary data 515 
Title: Increased Peptide YY blood concentrations, not decreased acyl-516 
ghrelin, are associated with reduced hunger and food intake in healthy 517 
older women: preliminary evidence  518 
Included here is additional information to supplement the methods and results sections of 519 
the main manuscript, including an analysis of the whole sample (men and women), the 520 
results for glucose, insulin, insulin resistance and gastric emptying times between the four 521 
age groups and details of the female only analysis. 522 
 523 
Methods 524 
Figure 4S: Overview of the test meal process, including all blood sampling points 525 
 526 
Figure 5S: Flow chart of screening process. 527 
 528 
 529 
Time   
(mins)   - 30   - 15   0   15   30   45   60   75   90   105   120   135   150   165   180   
Post  
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VAS                                          
Blood sample                                       
  
Start 
of 
study 
day
End of 
study 
day 
Cannula 
placed 
Ad libitum 
meal Standard 
meal 
58 completed 
132 Telephone 56 Excluded: 
25 illness / medication;  
24 Incorrect BMI;  
3 Withdrew;  
2 Lack of availability;  
2 Participation in other studies 
 
76 Full screenings 14 Excluded:  
4 illness / Medication; 
5 incorrect BMI;  
5 Withdrawals 
62 Recruited 4 Withdrawals:  
2 tolerability of blood sampling (1♂, 
1♀, 20-39yrs);  
2 non attendances (1♂, 1♀, 30-
49yrs) 
 
Results 530 
The characteristics of all subjects (both men and women) are shown in Table 4S.   531 
Table 5S shows the AUC and IAUC for each hormone, and 532 
Figure 6S shows the differences between age groups. 533 
Table 4S: Participants’ Characteristics (men and women) 534 
 Total 
N=58 
20-39 years 
N=18 
40-59 years 
N=18 
60-79 years 
N=16 
80+ years 
N=6 
Sex 
(male:female) 
27:31 
(47%:53%) 
9:9 9:9 9:7 0:6 
 Mean (SD) 
BMI (kg/m2) 23.5 (1.9) 22.6 (1.6) 23.7 (1.7) 24.1 (2.0) 23.5 (2.7) 
Lean Mass (%)* 20.1 (2.4)b 21.4 (2.8)a 20.1 (1.7) 19.7 (2.0)a 17.7 (1.1) 
 Median (Inter-quartile range) 
Weight (kg) 70.3 
(61.8-77.6) 
66.6  
(59.4-72.7) 
73.1 
(64.2-81.3) 
75.3  
(61.4-80.2) 
61.8  
(57.2-65.9) 
Body Fat (%)$ 25.3  
(17.1-31.3)a 
20.2  
(9.15-28.27) 
23.3  
(18.4-30.4) 
25.3  
(20.2-30.8)a 
33.9  
(31.4-37.0) 
Age (years) 54  
(29.8-65.5) 
25  
(22.8-29.3) 
53  
(43.8-56.0) 
66  
(61.5-71.5) 
84  
(80.8-89.8) 
      
a=1 missing value; b=2 missing values; BMI=Body Mass Index. 535 
* There was significant effect of age on lean mass percentage F(3,52)=4.84, p=0.005. Post 536 
hoc analysis using Hochberg test showed that the oldest group lower % lean mass 537 
compared to the youngest group at the 0.05 level. 538 
$Body fat percentage was significantly different between age groups, H(3)=12.7, p=0.005. 539 
Jonckheere’s test revealed a significant trend as expected; with increasing age the median 540 
fat % increased J=816.5, z=3.34, p=0.001. 541 
  542 
Table 5S: Mean area under the curve (AUC) and incremental AUC (IAUC) values for the plasma analysis (whole sample 543 
– men and women) 544 
Mean (sd) Total 
N=58 
20-39 
years 
N=18 
40-59 
years 
N=18 
60-79 
years 
N=16 
80+ years 
N=6 
P 
value 
Total Ghrelin 
AUC 
82007.0 
(44799) 
68315.5 
(32696) 
93323.3 
(46464) 
75895.4 
(50931) 
105430.5 
(46995) 
0.12 
IAUC -39409.0 
(46134) 
-29995.4 
(25917) 
-48104.9 
(44918) 
-35836.2 
(64145) 
-51089.8 
(44490) 
0.35 
Acyl Ghrelin 
AUC 
21011.6 
(15336) 
19875.4 
(13150) 
23294.5 
(19472) 
21194.6 
(14485) 
17083.0 
(11526) 
0.92 
IAUC -25835.7 
(33667) 
-29727.1 
(31040) 
-29681.5 
(45281) 
-19646.7 
(26751) 
-19127.7 
(15596) 
0.83 
PYY AUC 
 
5547.3 
(2532) 
5228.9 
(2093) 
5612.0 
(1783) 
5302.7 
(3333) 
6960.7 
(3334) 
0.40 
IAUC 1940.3 
(1969) 
1667.2 
(1689) 
1967.4 
(1127) 
1562.4 
(2775) 
3686.8 
(1637) 
0.02$ 
*GLP-1 AUC 
 
53936.0 
(22849) 
54163.7 
(23336) 
54682.2 
(25970) 
55141.4 
(19432) 
47924.0 
(25586) 
0.85 
IAUC 16109.5 
(16334) 
15389.9 
(12567) 
13876.9 
(23558) 
18571.5 
(9008) 
18029.0 
(19723) 
0.74 
*1 value missing (40-59yrs group). IAUC measured in pmol/l/min.   545 
$PYY IAUC was significantly different between age groups, H(3)=9.69, p=0.012 (tested 546 
using Kruskal-Wallis). Step-down follow-up analysis showed that the oldest age group had 547 
significantly higher IAUC compared to the youngest; however, there were no differences 548 
between the three youngest age groups, p=0.2. 549 
Data were not distributed consistently, some were skewed, some parametric. All are 550 
presented as mean and standard deviation and the appropriate comparative tests used. 551 
552 
Figure 6S: Difference in PYY, GLP-1 and Acyl-ghrelin blood concentrations between oldest and younger age groups. 553 
554 
 555 
 556 
 557 
  558 
 559 
 560 
  561 
 562 
Insulin, glucose and gastric emptying measurements  563 
 564 
Plasma insulin  565 
Table 6S shows the data for insulin levels, each age group, both men and women (3Sa), and 566 
females only (3Sb).  567 
Table 6Sa: Plasma insulin AUC and IAUC, in the 20-39, 40-59, 60-79 and 80+ age groups, for all patients. 568 
Age group* 
Plasma Insulin IAUC 
Mean (SD)  
Plasma Insulin AUC 
Mean (SD) 
20-39 (n=11) 4312.5 (1100.9) 6042.3 (1200.5) 
40-59 (n=11) 4462.7 (1391.6) 5912.2 (1675.2) 
60-79 (n=12) 4943.4 (2559.8) 6775.1 (2819.5) 
80+ (n=4) 5496.8 (1691.6) 8386.2 (1885.6) 
 569 
Table 3Sb: Plasma insulin AUC and IAUC, in the 20-39, 40-59, 60-79 and 80+ age groups, for females only. 570 
Age group* 
Plasma Insulin IAUC 
Mean (SD)  
Plasma Insulin AUC 
Mean (SD) 
20-39 (n=4) 4194.7 (1322.1) 6083.8 (1264.7) 
40-59 (n=5) 4530.5 (955.9) 6023.5 (1123.0) 
60-79 (n=4) 4770.9 (1012.5) 7074.9 (2376.6) 
80+ (n=4) 5496.8 (1691.6) 8386.2 (1885.6) 
*missing values due to haemolysed blood samples. Values (n=19) were imputed when there were 
no more than 2/6 values missing, the values were not from 0 or 180 time points, and the missing 
values were not consecutive. Values were imputed by calculating the rate of change between the 
two available values, multiplying by the time to the missing value, and adding on to the previous 
available value, using the following formula:  
Missing value= (difference between values immediately before and after)/(minutes between the 
two values)*(minutes of missing value from the last)+value before missing one 
 571 
Plasma insulin concentrations at each time point can be seen in Figure 7S, and AUC and 572 
IAUC in Figure 8S ((a) all patients; (b) females only).  AUC and IAUC scores for insulin 573 
increased with age but these differences did achieve significance. AUC is reported as the 574 
baseline for the older age group is higher and consequently the IAUC may mask differences. 575 
Lack of significance may be due to low numbers because of missing values. 576 
 577 
578 
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Figure 7S: Plasma insulin concentrations over the 3 hour test meal in the 20-39, 40-59, 60-79 and 80+ age groups: (a) All 579 
patients; (b) Females only. 580 
(a)  (b)  581 
 582 
Figure 8S: Plasma insulin AUC and IAUC in the 20-39, 40-59, 60-79 and 80+ age groups: (a) All patients; (b) Females only. 583 
(a)   584 
(b)   585 
 586 
587 
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Plasma glucose  588 
Data on plasma glucose is shown in Table 7S (a&b), Figure 9S and Figure 10S. For the whole 589 
group glucose AUC was significantly different between age groups, H(3)=9.75, p=0.021 590 
(tested using Kruskal-Wallis). Pairwise comparisons with adjusted p values showed that the 591 
oldest group had significantly higher AUC compared to the youngest (p=0.03), and there 592 
were no other significant differences.  IAUC scores were also the highest in the 80+ age 593 
group but this did not reach significance. For females only there were no significant 594 
differences between age categories for either IAUC or AUC glucose, possibly due to the 595 
reduced number of subjects.  596 
 597 
Table 7Sa: Plasma glucose AUC and IAUC, in the 20-39, 40-59, 60-79 and 80+ age groups, for all patients. 598 
Age group 
Plasma Glucose IAUC 
Mean (SD)  
Plasma Glucose AUC 
Mean (SD) 
20-39 (n=18) 121.1 (137.2) 939.6 (143.4) 
40-59 (n=18) 166.8 (215.7) 1057.3 (214.6) 
60-79 (n=16) 70.8 (237.9) 1077.7 (226.2) 
80+ (n=6) 227.1 (113.8) 1244.1 (363.2) 
 599 
Table 4Sb: Plasma glucose AUC and IAUC, in the 20-39, 40-59, 60-79 and 80+ age groups, for females only. 600 
Age group 
Plasma Glucose IAUC 
Mean (SD)  
Plasma Glucose AUC 
Mean (SD) 
20-39 (n=9) 121.1 (137.2) 928.8 (150.4) 
40-59 (n=9) 166.8 (215.7) 1046.5 (174.6) 
60-79 (n=7) 70.8 (237.9) 1113.0 (311.1) 
80+ (n=6) 227.1 (113.8) 1244.1 (363.2) 
 601 
Figure 9S: Plasma glucose concentrations over the 3 hour test meal in the 20-39, 40-59, 60-79 and 80+ age groups: (a) All 602 
patients; (b) Females only. 603 
(a) (b)  604 
 605 
606 
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Figure 10S: Plasma glucose AUC and IAUC in the 20-39, 40-59, 60-79 and 80+ age groups: (a) All patients; (b) Females 607 
only. 608 
(a)    609 
(b)   610 
 611 
612 
34 
 
Insulin resistance 613 
An index of fasting insulin resistance (HOMA) was measured using the following equation;  614 
HOMA = (glucose mmol/L x Insulin mU/L) / 22.5 615 
[where mU/L = pmol/7.5 (Raben et al.,2001)] 616 
 617 
Data is shown in Table 8S (a&b) and Figure 11S. The Kruskall-Wallis test showed that HOMA 618 
was significantly affected by age (H(3)=8.79, p=0.032). Pairwise comparisons with adjusted p 619 
values showed that HOMA was significantly higher in the oldest compared to the youngest 620 
(p=0.037) and the 40-59yrs group (p=0.033). All other comparisons did not indicate a 621 
difference.   For females only the pattern of data reminded the same by differences were 622 
not significant due to lower sample numbers. 623 
 624 
Table 8Sa: HOMA in the 20-39, 40-59, 60-79 and 80+ age groups, for all patients. 625 
Age group HOMA Median (IQ Range)  
20-39 (n=17) 0.20 (0.16 – 0.34) 
40-59 (n=16) 0.23 (0.15 – 0.36) 
60-79 (n=11) 0.20 (0.16 – 0.38) 
80+ (n=6) 0.59 (0.46 – 0.80) 
 626 
Table 5Sb: HOMA in the 20-39, 40-59, 60-79 and 80+ age groups, for females only. 627 
Age group HOMA Median (IQ Range)  
20-39 (n=8) 0.19 (0.13-0.41) 
40-59 (n=8) 0.27 (0.11-0.36) 
60-79 (n=3) 0.20 (0.13-0.66) 
80+ (n=6) 0.59 (0.46-0.80) 
 628 
Figure 11S: HOMA scores in the 20-39, 40-59, 60-79 and 80+ age groups: (a) All patients; (b) Females only. 629 
(a)  (b)  630 
 631 
 632 
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Paracetamol method- gastric emptying  633 
The time to peak concentration for paracetamol was used as a measurement of gastric 634 
emptying. Data is shown in Table 9S (a&b). Peak paracetamol concentrations did not change 635 
with age, no significance was detected between the four age groups for peak paracetamol 636 
concentrations in either all patients or females only. 637 
Table 9Sa: Peak paracetamol in the 20-39, 40-59, 60-79 and 80+ age groups, for all patients. 638 
Age group 
Time to peak paracetamol concentration  
Median (IQ Range)  
20-39 (n=18) 150 (26.3 – 180.0) 
40-59 (n=18) 180 (120.0 – 180.0) 
60-79 (n=16) 180 (60.0 – 180.0) 
80+ (n=6) 180 (97.5 – 180.0) 
 639 
Table 6Sb: Peak paracetamol in the 20-39, 40-59, 60-79 and 80+ age groups, for females only. 640 
Age group 
Time to peak paracetamol concentration 
Median (IQ Range)  
20-39 (n=9) 180 (75.0-180.0) 
40-59 (n=9) 180 (150.0-180.0) 
60-79 (n=7) 180 (120.0-180.0) 
80+ (n=6) 180 (97.5-180.0) 
 641 
642 
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Energy intake from ad libitum meal 643 
Table 10S shows the energy intake at the ad libitum meal by age group for all subjects (men 644 
and women), which was significantly different (p<0.001). Post hoc analysis (Hochberg) 645 
showed differences at the 0.05 level between the youngest and two oldest age groups (20-646 
39yrs vs 60-79 yrs & 80+ yrs).  Figure 12S shows the association with age when energy 647 
intake is controlled for lean mass; showing a negative correlation between energy intake 648 
(kcal)/lean body mass (kg) (p<0.001, r=-0.57) and age. 649 
Table 10S: Energy intake from ad libitum meal (men and women) 650 
Age group 
Energy intake (kcal) at ad 
libitum meal (sd) 
20-39 yrs 1018.9 (352.3) 
40-59 yrs 801.1 (275.3) 
60-79 yrs 638.7 (302.2) 
80+ yrs 415.62 (177.4) 
 651 
Figure 12S: Association between age and energy intake (kcal)/kg lean mass from the ad libitum meal (men and women). 652 
 653 
 654 
